| |
Article Title |
Author(s) |
Pages |
|
|
|
Cover 1
|
|
OFC
|
|
|
|
Masthead
Seminars in Oncology (ISSN 0093-7754) is published bimonthly by Elsevier, 360 Park Avenue South, New York, NY 10010-1710. Periodicals Postage Paid at New York, NY, and at additional mailing offices.
|
Michael J. Mastrangelo,
Ernest C. Borden
|
IFC
|
|
|
|
Improving Patient Outcomes in Glioblastoma Through Integration of Recent Data: Introduction
Glioblastoma (GBM) remains a highly treatment-refractory and aggressive primary brain tumor despite improvements in diagnosis and care. Challenges associated with the treatment of GBM result from its ...
|
Mark R. Gilbert
|
S1
|
|
|
|
Understanding Glioblastoma Tumor Biology: The Potential to Improve Current Diagnosis and Treatments
Glioblastoma (GBM) is a highly malignant brain cancer characterized by uncontrolled cellular proliferation, diffuse infiltration, a tendency for necrosis, significant angiogenesis, intense resistance ...
|
Santosh Kesari
|
S2-S10
|
|
|
|
The Impact of Recent Data on the Optimization of Standards of Care in Newly Diagnosed Glioblastoma
Glioblastoma is an aggressive form of brain cancer with a poor long-term prognosis. Treatment regimens for newly diagnosed disease range from surgical resection alone to surgery followed by radiothera...
|
Timothy Cloughesy
|
S11-S20
|
|
|
|
Recurrent Glioblastoma: A Fresh Look at Current Therapies and Emerging Novel Approaches
Despite international efforts, the treatment of recurrent glioblastoma (GBM) remains challenging. Although advances in surgical resection, the use of radiotherapy, and, predominantly, improved medical...
|
Mark R. Gilbert
|
S21-S33
|
|
| Frontmatter |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Table of Contents
|
|
A1
|
|
|
|
Improving Patient Outcomes in Glioblastoma Through Integration of Recent Data
Mark R. Gilbert, MD, Guest Editor
|
|
A2
|
|
|
|
Improving Patient Outcomes in Glioblastoma Through Integration of Recent Data
|
|
A3-A4
|
|
